Orphai Therapeutics Inc.
Records under this name other than the patents Orphai Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.
Showing 1 to 5 of 5 · Back to Orphai Therapeutics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,266,654 | Apilimod Compositions and Methods for Using Same Lapsed on the fee record Ended Mar 8, 2026 · Medium confidence | Lapsed on the fee record | Ended Mar 8, 2026 | Medium confidence |
| US 11,166,944 | Apilimod Compositions and Methods for Using Same in the Treatment of Renal Cancer Lapsed on the fee record Ended Nov 9, 2025 · Low confidence | Lapsed on the fee record | Ended Nov 9, 2025 | Low confidence |
| US 10,799,508 | Methods for treating cancer using HSP90 inhibitors Lapsed on the fee record Ended Oct 13, 2024 · High confidence | Lapsed on the fee record | Ended Oct 13, 2024 | High confidence |
| US 10,729,694 | Anti-Viral Compositions Containing Pikfyve Inhibitors and Use Thereof Lapsed on the fee record Ended Aug 4, 2024 · High confidence | Lapsed on the fee record | Ended Aug 4, 2024 | High confidence |
| US 10,702,534 | Compositions and Methods Relating to the Radioprotective Effects of Apilimod Lapsed on the fee record Ended Jul 7, 2024 · High confidence | Lapsed on the fee record | Ended Jul 7, 2024 | High confidence |